Gufic Biosciences Profile
Key Indicators
- Authorised Capital ₹ 85.75 Cr
as on 01-01-2025
- Paid Up Capital ₹ 10.03 Cr
as on 01-01-2025
- Company Age 40 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 511.39 Cr
as on 01-01-2025
- Satisfied Charges ₹ 201.51 Cr
as on 01-01-2025
- Revenue 59.18%
(FY 2022)
- Profit 116.68%
(FY 2022)
- Ebitda 73.64%
(FY 2022)
- Net Worth 55.17%
(FY 2022)
- Total Assets 32.99%
(FY 2022)
About Gufic Biosciences
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 509079 and on the National Stock Exchange(NSE) under GUFICBIO.
The Corporate was formerly known as Central Leasing Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 85.75 Cr and a paid-up capital of Rs 10.03 Cr.
The company currently has active open charges totaling ₹511.39 Cr. The company has closed loans amounting to ₹201.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Gufic Biosciences Limited India are Pranav Choksi as Ceo, Ami Shah as Company Secretary, and Devkinandan Roonghta as Cfo. Kamal Seth, Anu Aurora, Akshya Mahapatra, and Three other members serve as directors at the Company.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Gufic Biosciences?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranav Choksi  | CEO | 01-Apr-2015 | Current |
| Ami Shah | Company Secretary | 22-Mar-2016 | Current |
| Devkinandan Roonghta | CFO | 29-Oct-2018 | Current |
| Jayesh Choksi | Managing Director | 31-Aug-1999 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamal Seth | Director | 27-Jun-2024 | Current |
| Akshya Mahapatra | Additional Director | 14-Nov-2024 | Current |
| Anu Aurora | Director | 23-Dec-2019 | Current |
| Pankaj Gandhi | Whole-Time Director | 01-Aug-2013 | Current |
Financial Performance of Gufic Biosciences.
Gufic Biosciences Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 59.18% increase. The company also saw a substantial improvement in profitability, with a 116.68% increase in profit. The company's net worth Soared by an impressive increase of 55.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gufic Biosciences?
In 2022, Gufic Biosciences had a promoter holding of 75.48% and a public holding of 24.53%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indo-Vietnamese Chamber Of Commerce And IndustryActive 34 years 8 monthsKamal Seth is a mutual person
Gufic Private LimitedActive 53 years 10 monthsPankaj Gandhi, Pranav Choksi and 1 more are mutual person
Charges (Loans)
₹511.39 Cr
₹201.51 Cr
Charges Breakdown by Lending Institutions
- Others : 329.63 Cr
- Hdfc Bank Limited : 130.00 Cr
- Axis Bank Limited : 50.77 Cr
- The Saraswat Co-Op Bank Ltd : 0.80 Cr
- The Memon Co-Op.; Bank Ltd. : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jun 2024 | Others | ₹55.00 Cr | Open |
| 31 May 2024 | Others | ₹1.00 M | Open |
| 31 May 2024 | Others | ₹1.60 M | Open |
| 16 May 2024 | Others | ₹1.51 Cr | Open |
| 21 Aug 2023 | Others | ₹1.49 M | Open |
How Many Employees Work at Gufic Biosciences?
Gufic Biosciences has a workforce of 1522 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gufic Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gufic Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
